Alzheimer's Society comments on impact of coronavirus on medical research funding
1 min read
Hannah Churchill, Research Communications Manager at Alzheimer's Society said:
“The coronavirus pandemic has dealt a devastating blow to Alzheimer’s Society research investment. Over 90% of our funded researchers told us they were concerned about the future of dementia research, with good reason –we are not alone in having to pause our research funding programme and reduce research investment.
Before the pandemic, Alzheimer’s Society had been accelerating funding into vital medical research, not only into new treatments for dementia but invaluable care research, improving the lives of the 850,000 people living with dementia today.
People with dementia have been hit hardest by the coronavirus pandemic so we must make sure that the hope that research provides is not snatched away. With the sector estimating that it will take 4.5 years for their medical research spend to return to normal levels, we are calling for emergency financial support from the Government so we can continue funding our life-saving research.”
